ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/
BankPosition in NVS — Novartis AG
CIK 109380
SALT LAKE CITY, UT
Position in NVS
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$49,836
+$1,262 QoQ
Shares Held
318
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,432
of 1,603 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 50%
Shared 0%
None 50%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ holds $49,893,702 across 14 Drug Manufacturers - General names. NVS ranks #12 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
41,284 | $10,388,705 | |
| 2 | SNY |
Sanofi
|
193,917 | $8,272,499 | |
| 3 | PFE |
Pfizer Inc
|
318,425 | $7,667,674 | |
| 4 | LLY |
ELI LILLY & Co
|
5,146 | $6,172,267 | |
| 5 | MRK |
Merck & Co., Inc.
|
45,178 | $5,805,373 | |
| 6 | AMGN |
Amgen Inc
|
14,352 | $5,197,146 | |
| 7 | JNJ |
Johnson & Johnson
|
14,076 | $3,574,881 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
10,854 | $1,371,294 |
All Filings in NVS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $49,836 | 318 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $48,574 | 318 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $46,737 | 339 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $43,216 | 337 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $52,275 | 432 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $56,742 | 509 | Shares | Sole | 2025-05-12 | |
| No filing history on record for this holder in this stock. | ||||||